Publisher's Synopsis
GLP-1 (Glucagon-Like Peptide-1) is a hormone that plays a crucial role in regulating blood sugar levels and appetite. It is released from the intestines in response to food intake and stimulates the release of insulin from the pancreas, which helps lower blood sugar levels. Additionally, GLP-1 slows down the emptying of the stomach, leading to increased feelings of fullness and reduced food intake. In the context of weight management, GLP-1-based medications are used to help individuals with obesity or type 2 diabetes control their weight. These medications mimic the effects of GLP-1 in the body, leading to improved blood sugar control, reduced appetite, and potential weight loss. An integrative approach to weight management involving GLP-1 therapy may include a combination of lifestyle modifications, dietary changes, exercise, stress management, and the use of medications like GLP-1 agonists. Integrative medicine focuses on treating the whole person, addressing the root causes of weight gain, and promoting overall health and well-being.
